Table 3
Number of cancers and percentage linking with at least one Discharge Abstract Database record during follow-up, by type of cancer, province (excluding Quebec) and analytical institution type, 2005 to 2008

Table 3
Number of cancers and percentage linking with at least one Discharge Abstract Database record during follow-up, by type of cancer, province (excluding Quebec) and analytical institution type, 2005 to 2008
Table summary
This table displays the results of Number of cancers and percentage linking with at least one Discharge Abstract Database record during follow-up. The information is grouped by Province and analytical institutional type (appearing as row headers), Type of cancer (appearing as column headers).
Province and analytical institutional type Type of cancer
Prostate Female breast Colorectal Lung
Newfoundland and Labrador  
N 1,556 1,289 1,867 1,306
% 91.6 98.1 98.7 94.4
% AC 63.8 83.5 95.2 85.2
Prince Edward Island  
N 536 370 417 465
% 83.4 96.8 98.6 96.3
% AC 64.4 93.2 94.2 86.2
Nova Scotia  
N 3,270 2,903 3,231 3,457
% 87.2 96.2 97.4 94.0
% AC 64.9 79.2 92.6 84.5
New Brunswick  
N 2,952 2,148 2,106 2,802
% 79.5 97.2 97.0 94.9
% AC 58.7 77.6 95.8 91.4
Ontario  
N 36,600 31,288 29,684 30,052
% 62.6 56.9 93.5 87.4
% AC 62.6 56.8 93.5 87.3
Manitoba  
N 2,561 3,124 3,139 3,289
% 77.2 95.6 97.8 94.1
% AC 64.3 71.6 92.9 85.4
Saskatchewan  
N 3,231 2,667 2,729 2,803
% 86.9 97.5 98.0 94.5
% AC 60.9 91.8 94.4 89.9
Alberta  
N 8,282 7,646 6,635 7,052
% 65.7 86.4 94.4 84.8
% AC 65.4 86.3 94.2 83.8
British Columbia  
N 12,328 11,131 10,260 11,037
% 80.9 95.6 96.9 92.8
% AC 58.1 76.2 92.9 81.8
N = number of registered cancers with valid health insurance number
% = percentage of cancers linked to at least one Discharge Abstract Database record during follow-up
% AC = percentage of cancers linked to at least one Discharge Abstract Database record, submitted by an acute care institution, during follow-up
Notes: Follow-up period for colorectal, lung and female breast cancer extended from 31 days before to 365 days after Canadian Cancer Registry date of diagnosis; for prostate cancer, follow-up extended from 31 days before to 730 days after date of diagnosis.
Sources: Canadian Cancer Registry data file, April 4, 2012; Discharge Abstract Database, fiscal years 2004/2005 to 2010/2011.
Date modified: